Ecaterina Iavrumov

Dr. Ecaterina Iavrumov

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EIEcaterina Iavrumov
Ecaterina Iavrumov
DCDumitru Cravcenco
Dumitru Cravcenco
Alexandr Ceasovschih, Assist. Prof., PhDAlexandr Ceasovschih, Assist. Prof., PhD
Alexandr Ceasovschih, Assist. Prof., PhD
Pradeesh SivapalanPradeesh Sivapalan
Pradeesh Sivapalan
NSNikolaos Siafakas
Nikolaos Siafakas
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
Purpose: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition often accompanied by various comorbidities that significantly affect patient outcomes. High resolution computed tomography (HRCT) has emerged as a valuable tool for diagnosing and managing COPD-related comorbidities. This study aimed to explore the impact of chest computed tomography (CT) imaging in identifying and characterizing comorbidities in COPD patients. Methods: The study was conducted on 99 patients with COPD, the median age of the study population was 70.0 years (Q1–Q3: 62.0–75.0); 86% were men (85), and 14% were women (14). All patients underwent chest HRCT to identify the presence of comorbidities. Results: According to the GOLD classification (ABE groups), 3% were type A, 27% were type B, and 69% were type E. The prevalence of comorbidities identified on chest HRCT was reported as 66% for coronary artery calcification (CAC), 83% for osteoporosis, 36% for pulmonary artery enlargement (PAE), 31% for emphysema, 19% for bronchiectasis, 17% for hiatal hernia, 14% for lung cancer, 12% pulmonary infections, and 3% for interstitial abnormalities. In 4%, there were no comorbidities, one comorbidity was found in 11%, two comorbidities in 17%, and three comorbidities and more in 68% of cases. Conclusions: Chest HRCT imaging serves as a valuable tool for identifying and assessing comorbidities in patients with COPD. Incorporating chest CT imaging into the routine evaluation of COPD patients may contribute to a more comprehensive understanding of their condition and lead to better clinical outcomes.

5 September 2026
Verified
Conference Paper
Closed access
EIEcaterina Iavrumov
Ecaterina Iavrumov
ACAlexandru Corlateanu
Alexandru Corlateanu
Background: Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic condition frequently accompanied by multiple comorbidities. While comorbidity burden has been extensively studied, less is known about distinct multimorbidity patterns and their relationship with disease severity. Identifying such patterns may improve clinical phenotyping and risk stratification. Methods. Cross-sectional study of 180 spirometry-confirmed COPD patients. Comorbidities were recorded and hierarchical cluster analysis identified multimorbidity patterns. Severity was assessed by FEV₁ (% predicted), GOLD 2026 ABE, CAT, mMRC, exacerbations and hospitalizations in the previous year, and all-cause mortality. Logistic regression evaluated independent associations with severe COPD and mortality. Results. Three clusters were identified: cardiovascular–metabolic (41%), psychiatric–symptomatic (31%), and musculoskeletal–frailty (28%). The cardiovascular–metabolic cluster had higher GOLD E prevalence (70% vs 48% and 52%; p=0.011), lower FEV₁ (40% vs 48% and 46%; p=0.019), more hospitalizations (1.6 vs 0.8 and 0.9; p=0.004), and higher mortality (8% vs 3,5% and 4%; p=0.038). It independently predicted severe COPD (OR 2.89; p=0.003) and mortality (OR 2.42; p=0.031). Conclusions. Distinct multimorbidity clusters are present in COPD and are differentially associated with disease severity, hospitalization burden and mortality. Cluster-based phenotyping may refine GOLD classification and improve risk stratification beyond spirometric assessment alone.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
EIEcaterina Iavrumov
Ecaterina Iavrumov
DCDumitru Cravcenco
Dumitru Cravcenco
ILIon Luca
Ion Luca
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
Background and objective: COPD is a progressive respiratory condition often accompanied by various comorbidities that significantly affect patient outcomes. HRCT imaging has emerged as a valuable tool for diagnosing and managing COPD-related comorbidities. This study aims to explore the impact of chest CT imaging in identifying and characterizing comorbidities in COPD patients. Methods: The study was conducted on 99 patients with COPD, with an average age of 67,8 (37-88), 85% were men (85), and 14% were women (14). The patients underwent chest computed tomography to identify the presence of imaging comorbidities. Results: According to the GOLD classification, ABE type, 3% were type A, 27% were type B, and 69% were type E. The prevalence of comorbidities identified on chest HRCT was reported as 66% for coronary artery calcification, 83% for osteoporosis, 36% for pulmonary artery enlargement, 31% for emphysema, 19% for bronchiectasis, 17% for hiatal hernia, 14% for lung cancer, 12% pulmonary infections and 3% for interstitial abnormalities. In 4% there were no comorbidities, one comorbidity was found in 11%, two comorbidities in 17%, and three comorbidities and more in 68% of cases. Conclusion: Chest CT imaging serves as a valuable tool for identifying and assessing comorbidities in patients with COPD. Incorporating chest CT imaging into the routine evaluation of COPD patients can contribute to a more comprehensive understanding of their condition and lead to better clinical outcomes. KEYWORDS COPD, comorbidities, chest HRCT, chest computed tomography

1 September 2025 in Moldovan Journal of Health Sciences
Verified
Journal Article
Closed access
EIEcaterina Iavrumov
Ecaterina Iavrumov
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
Introduction. Chronic obstructive pulmonary disease is a major cause of morbidity and mortality worldwide, often associated with multiple comorbidities that may complicate its clinical course. These comorbidities can exacerbate respiratory symptoms, impair lung function, alter imaging findings, and significantly affect prognosis. Material and methods. This analytical, observational, cross-sectional study included 80 patients with confirmed chronic obstructive pulmonary disease, divided into two equal subgroups according to spirometric severity: GOLD 1-2 (n = 40) and GOLD 3-4 (n = 40). Clinical, functional, and radiological parameters were evaluated. Comorbidity burden was assessed using validated composite indices: Charlson Comorbidity Index, COTE, COPDCoRi, CODEX, and COMCOLD. Associations between comorbidity scores, pulmonary function, high-resolution computed tomography findings, and clinical outcomes were analyzed using SPSS v22.0. A p-value less than 0.05 was considered statistically significant. Results. The presence of comorbidities was high across all domains, with only minor differences between spirometric stages. Structural abnormalities (emphysema, bronchiectasis, pulmonary hypertension) were more prevalent in GOLD 3-4 patients. A strong correlation was observed between composite indices and parameters such as forced expiratory volume in 1 second, dyspnea, exacerbation rate, radiological findings, and GOLD stages. Logistic regression models showed that the combination of COPD-specific indices (COTE, CODEX, COPDCoRi) significantly outperformed the Charlson index in predicting severe COPD (AUC 0.86 vs. 0.63). High-resolution computed tomography findings variables also demonstrated strong predictive value (AUC 0.81). Conclusions. Comorbidities play a central role in shaping chronic obstructive pulmonary disease severity and prognosis. The integration of composite comorbidity indices and imaging biomarkers enhances multidimensional patient stratification, aligning with GOLD 2024 recommendations for personalized care

4 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EIEcaterina Iavrumov
Ecaterina Iavrumov
DCDumitru Cravcenco
Dumitru Cravcenco
Alexandr Ceasovschih, Assist. Prof., PhDAlexandr Ceasovschih, Assist. Prof., PhD
Alexandr Ceasovschih, Assist. Prof., PhD
Pradeesh SivapalanPradeesh Sivapalan
Pradeesh Sivapalan
NSNikolaos Siafakas
Nikolaos Siafakas
Alexandru CorlateanuAlexandru Corlateanu
Alexandru Corlateanu
Purpose: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition often accompanied by various comorbidities that significantly affect patient outcomes. High resolution computed tomography has emerged as a valuable tool for diagnosing and managing COPD-related comorbidities. This study aims to explore the impact of chest CT imaging in identifying and characterizing comorbidities in COPD patients. Methods: The study was conducted on 99 patients with COPD, with an average age of 67,8 (37-88), 86% were men (85), and 14% were women (14). The patients underwent chest HRCT to identify the presence of comorbidities. Results: According to the GOLD classification, ABE type, 3% were type A, 27% were type B, and 69% were type E. The prevalence of comorbidities identified on chest HRCT was reported as 66% for coronary artery calcification (CAC), 83% for osteoporosis, 36% for pulmonary artery enlargement (PAE), 31% for emphysema, 19% for bronchiectasis, 17% for hiatal hernia, 14% for lung cancer, 12% pulmonary infections and 3% for interstitial abnormalities. In 4% there were no comorbidities, one comorbidity was found in 11%, two comorbidities in 17%, and three comorbidities and more in 68% of cases. Conclusion: Chest HRCT imaging serves as a valuable tool for identifying and assessing comorbidities in patients with COPD. Incorporating chest CT imaging into the routine evaluation of COPD patients can contribute to a more comprehensive understanding of their condition and lead to better clinical outcomes.